Hormone Replacement Therapy for the Prevention of Chronic Conditions in Postmenopausal Women

Release Date: May 2005

Summary of Recommendations / Supporting Documents

Summary of Recommendations

• The U.S. Preventive Services Task Force (USPSTF) recommends against the routine use of combined estrogen and progestin for the prevention of chronic conditions in postmenopausal women.
  Grade: D Recommendation.
• The USPSTF recommends against the routine use of unopposed estrogen for the prevention of chronic conditions in postmenopausal women who have had a hysterectomy.
  Grade: D Recommendation.

Top of Page

Supporting Documents

Hormone Replacement Therapy, May 2005
Recommendation Statement (PDF File, 102 KB; PDF Help)
Summary of the Evidence, 2002 (PDF File, 138 KB; PDF Help)
Systematic Evidence Reviews, August 2002:
   HRT and Breast Cancer (PDF Files Download)
   HRT and Cardiovascular Disease (PDF Files Download)
   HRT and Cognition (PDF Files Download)
   HRT and Osteoporosis (PDF Files Download)
   HRT and Venous Thromboembolism (PDF Files Download)

Top of Page

Current as of May 2005

Internet Citation:

Hormone Replacement Therapy for the Prevention of Chronic Conditions in Postmenopausal Women, Topic Page. May 2005. U.S. Preventive Services Task Force. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/uspstf/uspspmho.htm